1. Treatment Options in Prostate Cancer Once Primary Therapy Fails
Thomas Keane, David Gillatt, Colleen Lawton, Heather Payne, Bertrand Tombal 
European Urology Supplements 
Volume 6, Issue 3, Pages (March 2007)
DOI: /j.eursup
Copyright © 2006 European Association of Urology Terms and Conditions

2. Fig. 1
Casodex 150mg improves objective progression-free survival in locally advanced prostate cancer, irrespective of primary therapy [17]. Reprinted from McLeod DG, et al. BJU Int 2006;97:247–54, with permission from Blackwell Publishing.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions